President, Cholesterol, Genetics and Heart Disease Institute
Cardiology
Dr. Harold R. Superko, MD
|
|
Give Review
Dr. Harold R. Superko is an expert in the field of Cardiology. He studied medicine at Stony Brook University School of Medicine. Harold Superko has written publications. He has 81 publications published with PubMed. The lastest publication is: 'Did grandma give you heart disease? The new battle against coronary artery disease.'
Publications
- Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD.
- Non-Traditional Markers of Cardiovascular Disease Risk Can Improve the 2013 ACC/AHA Prevention Guidelines: Insights From the MESA Investigation.
- Providing patients with pharmacogenetic test results affects adherence to statin therapy: results of the Additional KIF6 Risk Offers Better Adherence to Statins (AKROB...
- Omega-3 Fatty Acid blood levels: clinical significance and controversy.
- High-density lipoprotein subclasses and their relationship to cardiovascular disease.
- Omega-3 Fatty Acid Blood Levels Clinical Significance Update.
- Small LDL and hsCRP as new risk factors for coronary artery disease.
- Metabolic disorders contribute to subclinical coronary atherosclerosis in patients with coronary calcification.
- Electron beam tomography and National Cholesterol Education Program guidelines in asymptomatic women.
- Relation of coronary artery calcium identified by electron beam tomography to serum lipoprotein levels and implications for treatment.
- Small, dense, low-density lipoprotein and atherosclerosis.
- Small, dense low-density lipoprotein subclass pattern B: issues for the clinician.
- Garlic powder, effect on plasma lipids, postprandial lipemia, low-density lipoprotein particle size, high-density lipoprotein subclass distribution and lipoprotein(a).
- Long-term blood cholesterol-lowering effects of a dietary fiber supplement.
- Setting up a preventive cardiology program in the real world.
- Did grandma give you heart disease? The new battle against coronary artery disease.
- Effectiveness of once-nightly dosing of extended-release niacin alone and in combination for hypercholesterolemia.
- Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia.
- Inclusion of lipoprotein subfractions among efficacy parameters.
- Effect of fluvastatin on low-density lipoprotein peak particle diameter.
- The new thinking on lipids and coronary artery disease.
- What can we learn about dense low density lipoprotein and lipoprotein particles from clinical trials?
- Elevated high-density lipoprotein cholesterol, not protective in the presence of homocysteinemia.
- Lipid disorders contributing to coronary heart disease: an update.
- Beyond LDL cholesterol reduction.
- Cost-effective treatment of coronary artery disease--the new imperative.
- 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 4. Efficacy of risk factor management.
- Exercise and lipoprotein metabolism.
- Effects of cessation of caffeinated-coffee consumption on ambulatory and resting blood pressure in men.
- A case-management system for coronary risk factor modification after acute myocardial infarction.
- Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford...
- Association of lipoprotein subclass distribution with use of selective and non-selective beta-blocker medications in patients with coronary heart disease.
- Coronary artery disease regression. Convincing evidence for the benefit of aggressive lipoprotein management.
- Failure of cholesterol treatment in patients with coronary artery disease: a cost-effective solution.
- New aspects in lipidology and atherosclerosis.
- Sophisticated primary and secondary atherosclerosis prevention is cost effective.
- New aspects of risk factors for the development of atherosclerosis, including small low-density lipoprotein, homocyst(e)ine, and lipoprotein(a).
- Dairy product consumption.
- Effects of ozone inhalation during exercise in selected patients with heart disease.
- Coronary heart disease and risk factor modification. Is there a threshold?
- Associations of resting heart rate with concentrations of lipoprotein subfractions in sedentary men.
- Modification of plasma cholesterol through exercise. Rationale and recommendations.
- High-density lipoprotein cholesterol measurements. A help or hindrance in practical clinical medicine?
- The role of exercise training in the therapy of hyperlipoproteinemia.
- Blood cholesterol treatment attitudes of community physicians: a major problem.
- Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise.
- Effect of alpha- and selective beta-blockade for hypertension control on plasma lipoproteins, apoproteins, lipoprotein subclasses, and postprandial lipemia.
- Effects of solid and liquid guar gum on plasma cholesterol and triglyceride concentrations in moderate hypercholesterolemia.
- Drug therapy and the prevention of atherosclerosis in humans.
- A review of combined hyperlipidaemia and its treatment with fenofibrate.
- Training for intermediate clinical lipid specialists.
- Lipoprotein and hepatic lipase activity and high-density lipoprotein subclasses after cardiac transplantation.
- Prevention and regression of atherosclerosis with drug therapy.
- Exercise training, serum lipids, and lipoprotein particles: is there a change threshold?
- Caffeinated and decaffeinated coffee effects on plasma lipoprotein cholesterol, apolipoproteins, and lipase activity: a controlled, randomized trial.
- The effect of apolipoprotein E isoform difference on postprandial lipoprotein in patients matched for triglycerides, LDL-cholesterol, and HDL-cholesterol.
- Differential effects of nicotinic acid in subjects with different LDL subclass patterns.
- Effectiveness of low-dose colestipol therapy in patients with moderate hypercholesterolemia.
- Effects of acute and chronic alcohol consumption on postprandial lipemia in healthy normotriglyceridemic men.
- Current and future trends in therapy for dyslipidemias.
- Prediction of native coronary artery disease progression following PTCA or CABG in the Emory Angioplasty Versus Surgery Trial.
- Smallest LDL particles are most strongly related to coronary disease progression in men.
- Small LDL and its clinical importance as a new CAD risk factor: a female case study.
- Genetic testing for early detection of individuals at risk of coronary heart disease and monitoring response to therapy: challenges and promises.
- Firefighters, heart disease, and aspects of insulin resistance: the FEMA Firefighter Heart Disease Prevention study.
- Combination of niacin extended-release and simvastatin results in a less atherogenic lipid profile than atorvastatin monotherapy.
- Family coronary heart disease: a call to action.
- KIF6 polymorphism as a predictor of risk of coronary events and of clinical event reduction by statin therapy.
- Statins in acute coronary syndromes and genetic insight.
- Letter by Superko and King regarding article, "Lipid Treatment Assessment Project 2: a multinational survey to evaluate the proportion of patients achieving low-densit...
- Cardiovascular event risk: high-density lipoprotein and paraoxonase.
- Advanced lipoprotein testing and subfractionation are clinically useful.
- Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprot...
- Influence of symptomatic status on the prevalence of obstructive coronary artery disease in patients with zero calcium score.
- Is it LDL particle size or number that correlates with risk for cardiovascular disease?
- Lipid management to reduce cardiovascular risk: a new strategy is required.
- Gemfibrozil reduces small low-density lipoprotein more in normolipemic subjects classified as low-density lipoprotein pattern B compared with pattern A.
- High-density lipoprotein subclass distribution in individuals of Asian Indian descent: the National Asian Indian Heart Disease Project.
- Sophisticated tests for susceptibility to atherosclerosis: an added value for heart hospitals.
- Differential effect of two nicotinic acid preparations on low-density lipoprotein subclass distribution in patients classified as low-density lipoprotein pattern A, B,...
Schools
State University of New York Health Science Center At Stony Brook
Doctors Specialties
- Cardiology
Accepted Insurances
Education
-
University of California Davis -
Stony Brook University School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Robert D. Hoff, MD |
|
|
Dr. Sonjoy R. Laskar, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jack P. Chen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samuel C. Dudley Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jeffrey L. Clark, MD |
|
|
Dr. Gregory R. Hartlage, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Laurence S. Sperling, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Basil Margolis, MD |
|
|
Dr. Paolo Raggi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Anekwe Onwuanyi, MB
This Doctor is OpenDoctor Recommended.
|
|
|
Kathleen A. Halvey, NP |
|
|
Patricia Simpson, CFNP |
|
|
Robert A. Schwartz |